Medicare Enrolled
Dr. Rabia Parveez, MD
Hematology & Oncology · Fresno, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Parveez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Parveez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Parveez
Dr. Rabia Parveez is a hematology & oncology specialist in Fresno, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Parveez performed 193,501 Medicare services across 5,052 unique beneficiaries.
Between the years covered by Open Payments, Dr. Parveez received a total of $26,371 from 54 pharmaceutical and/or device companies across 423 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Parveez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$26,371 industry payments
Medicare Practice Summary
Medicare Utilization ↗193,501
Medicare services
Top 3% in CA for hematology & oncology
5,052
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10,184 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
58,500 | $1 | $9 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
47,900 | $2 | $12 |
| Filgrastim-ayow biosimilar injection, 1 microgram An injection of the biosimilar medication filgrastim-ayow (Releuko) at a dose of 1 microgram. |
36,180 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 7,540 | $1 | $11 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
6,800 | $0 | $8 |
| Nivolumab injection (Opdivo) | 6,660 | $24 | $72 |
| Denosumab injection (Prolia/Xgeva) | 4,500 | $18 | $51 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
3,330 | $36 | $118 |
| Injection, granisetron, extended-release, 0.1 mg | 3,300 | $5 | $20 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
3,175 | $0 | $1 |
| Iron infusion (Monoferric) | 2,100 | $16 | $62 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,738 | $8 | $11 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,738 | $8 | $20 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,243 | $0 | $8 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
819 | $11 | $40 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
794 | $97 | $418 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
788 | $10 | $27 |
| Injection, leucovorin calcium, per 50 mg | 518 | $3 | $13 |
| Anti-nausea injection (Aloxi/palonosetron) | 440 | $1 | $10 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
435 | $2 | $10 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
359 | $13 | $35 |
| Iron level test | 345 | $6 | $17 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
344 | $9 | $22 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
344 | $67 | $286 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
296 | $1 | $10 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
285 | $24 | $87 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
247 | $142 | $558 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
231 | $96 | $252 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
213 | $51 | $198 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
198 | $110 | $400 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
176 | $15 | $38 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
173 | $14 | $37 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
133 | $1 | $9 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
127 | $4 | $11 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
114 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
105 | $24 | $84 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
90 | $17 | $61 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
89 | $9 | $24 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
86 | $61 | $222 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
69 | $1,360 | $4,921 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
68 | $140 | $521 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 65 | $285 | $898 |
| Electrophoresis laboratory test A laboratory testing technique that separates molecules based on their size and electrical charge. |
63 | $59 | $154 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
61 | $55 | $194 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
56 | $50 | $145 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
55 | $4 | $14 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $120 | $450 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
49 | $13 | $47 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
43 | $4 | $12 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
43 | $29 | $90 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
41 | $12 | $32 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
39 | $77 | $375 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
34 | $4 | $10 |
| Prolonged intravenous chemotherapy administration This procedure involves the administration of chemotherapy medication directly into a vein over an extended period. |
32 | $107 | $410 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
32 | $48 | $256 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
31 | $19 | $48 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
31 | $17 | $58 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
29 | $47 | $171 |
| New patient office visit, complex (60-74 min) | 27 | $171 | $594 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
22 | $248 | $943 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
20 | $6 | $16 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
17 | $16 | $42 |
| Coagulation assessment blood test A blood test that measures how long it takes for blood to clot. The sample can be plasma or whole blood. |
15 | $6 | $16 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
14 | $4 | $11 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
13 | $123 | $628 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
13 | $32 | $307 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
12 | $72 | $153 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
33.5% high complexity
62.2% medium
4.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$26,371
Total received (2018-2024)
Avg $3,767/year across 7 years
Top 17% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
423
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,305 (50.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,826 (25.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,240 (23.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,916
2023
$1,179
2022
$1,710
2021
$9,683
2020
$5,993
2019
$5,875
2018
$14
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$246
Celgene Corporation
$242
GlaxoSmithKline, LLC.
$202
Exelixis Inc.
$134
Daiichi Sankyo Inc.
$130
ABBVIE INC.
$124
Novartis Pharmaceuticals Corporation
$101
Lilly USA, LLC
$76
Takeda Pharmaceuticals U.S.A., Inc.
$67
Ipsen Biopharmaceuticals, Inc
$60
Merck Sharp & Dohme LLC
$59
PFIZER INC.
$57
Regeneron Healthcare Solutions, Inc.
$55
SOBI, INC
$46
E.R. Squibb & Sons, L.L.C.
$43
EMD Serono, Inc.
$42
BeiGene USA, Inc.
$36
Sirtex Medical Inc
$35
SERVIER PHARMACEUTICALS LLC
$34
Pharmacosmos Therapeutics Inc.
$30
Eisai Inc.
$25
Incyte Corporation
$22
Janssen Biotech, Inc.
$20
Genentech USA, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 36.0% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$7,217
Acceleron Pharma, Inc.
$3,160
Pharmacosmos Therapeutics Inc.
$2,430
Karyopharm Therapeutics Inc.
$2,334
E.R. Squibb & Sons, L.L.C.
$2,206
Exelixis Inc.
$1,890
Epizyme, Inc.,
$1,263
Rigel Pharmaceuticals, Inc.
$1,200
AstraZeneca Pharmaceuticals LP
$590
Daiichi Sankyo Inc.
$440
Novartis Pharmaceuticals Corporation
$381
GlaxoSmithKline, LLC.
$343
Kite Pharma, Inc.
$224
Astellas Pharma US Inc
$200
Regeneron Healthcare Solutions, Inc.
$145
Takeda Pharmaceuticals U.S.A., Inc.
$143
Janssen Biotech, Inc.
$135
Clovis Oncology, Inc.
$135
Pharmacyclics LLC, An AbbVie Company
$128
Amgen Inc.
$127
ABBVIE INC.
$124
Ipsen Biopharmaceuticals, Inc
$121
Lilly USA, LLC
$115
Incyte Corporation
$113
Merck Sharp & Dohme LLC
$88
TerSera Therapeutics LLC
$84
PFIZER INC.
$74
SOBI, INC
$72
Pharmacyclics LLC, an AbbVie Company
$70
EMD Serono, Inc.
$65
BeiGene USA, Inc.
$64
Gilead Sciences, Inc.
$56
SANOFI-AVENTIS U.S. LLC
$55
Alexion Pharmaceuticals, Inc.
$54
Merck Sharp & Dohme Corporation
$54
GENZYME CORPORATION
$47
Sirtex Medical Inc
$43
Genentech USA, Inc.
$43
Eisai Inc.
$36
Myovant Sciences Inc.
$35
SERVIER PHARMACEUTICALS LLC
$34
Seagen Inc.
$32
Acrotech Biopharma LLC
$28
Sobi, Inc
$28
Dova Pharmaceuticals
$18
PUMA BIOTECHNOLOGY, INC.
$18
Bayer HealthCare Pharmaceuticals Inc.
$17
Apellis Pharmaceuticals, Inc.
$15
Deciphera Pharmaceuticals Inc.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
PharmaEssentia USA Corporation
$14
EISAI INC.
$13
TESARO, Inc.
$12
Advanced Accelerator Applications
$11
Top 3 companies account for 48.6% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · Monoferric · NERLYNX · NINLARO · Neulasta · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PLUVICTO · Phesgo · Pomalyst · QINLOCK · REBLOZYL · Reblozyl · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · Tavalisse · Tazverik · Tibsovo · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · XGEVA · XPOVIO · YERVOY · Yescarta · ZEJULA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (50%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Hematology & oncology specialists within 10 mi
28
Per 100K population
2.8
County median income
$71,434
Nearest hospital
SAINT AGNES MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Parveez is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with consulting-driven industry engagement in the top 17% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Parveez experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Parveez performed 58,500 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Parveez receive payments from pharmaceutical companies?
Yes. Dr. Parveez received a total of $26,371 from 54 companies across 423 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Parveez's costs compare to other hematology & oncology specialists in Fresno?
Dr. Parveez's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Parveez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fresno
Browse hematology & oncology specialists in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Acceleron Pharma, Inc. Payments to Doctors
See all physicians who received payments from Acceleron Pharma, Inc.
By company
Pharmacosmos Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Pharmacosmos Therapeutics Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology